Contagion, December 2020 (Vol. 05 No. 06)
A Case of Pneumonia and Bacteremia in a Trauma Patient Caused by Bordetella hinzii
December 28, 2020
Article
Case Study
Emerging Options for Treatment and Prevention of HIV Infection
December 27, 2020
Article
Peer Exchange
An expert panel discussion around long-acting injectables' role in both preventing and treating HIV.
The Role of Antimicrobial Stewardship in the Treatment of C difficile
December 26, 2020
Article
Stewardship and Prevention
Biologics have become a novel treatment in recurrent C. difficile.
IDSA Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections
December 25, 2020
Article
Multidrug-Resistant Infections
Since late 2004, 7 novel antibiotics with activity against ESBL-E, CRE, and/or DTR P aeruginosa have been approved.
Fostemsavir for Multidrug Resistant HIV-1: It’s Time for HIV to Overcome Attachment Issues With CD4 Cells
December 22, 2020
Article
News and Breakthroughs
Fostemsavir, an HIV-1 attachment inhibitor, is a novel therapeutic option for multidrug-resistant HIV. It represents the first oral agent developed for this indication in over a decade and provides promise for patients with limited remaining treatment options.
Entering the Phase of Phage: A Closer Look at Bacteriophage Therapy
December 20, 2020
Article
In the Literature
Emergency Use Authorizations for COVID-19 Therapeutics: The Good, the Bad, and the Data-Deficient
December 19, 2020
Article
Editor-in-Chief Letter
Holiday Guest List—When the Uninvited Arrive: COVID-19 and Coinfections
December 18, 2020
Article
Acute Infections